FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

K Furuya

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Physiology

Cerebrovascular Circulation

Procedures

Anatomy

Concepts & Ideas

Body Weight

Co-author Network

Publications

TOP 3
K Furuya; H Takeda; Salman Azhar; Richard M McCarron; Y Chen; Christl Ruetzler; K M Wolcott; Thomas J DeGraba; R Rothlein; T E Hugli; Gregory J del Zoppo; John M Hallenbeck
Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study.
C Zimmermann; Irene Ginis; K Furuya; Dace Klimanis; Christl Ruetzler; Maria Spatz; John M Hallenbeck
Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.
Christl Ruetzler; K Furuya; H Takeda; John M Hallenbeck
Brain vessels normally undergo cyclic activation and inactivation: evidence from tumor necrosis factor-alpha, heme oxygenase-1, and manganese superoxide dismutase immunostaining of vessels and perivascular brain cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of K Furuya (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: K Furuya; H Takeda; Salman Azhar; Richard M McCarron; Y Chen; Christl Ruetzler; K M Wolcott; Thomas J DeGraba; R Rothlein; T E Hugli; Gregory J del Zoppo; John M Hallenbeck
Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study.
Stroke; a journal of cerebral circulation 2001;32(11):2665-74.
2001: C Zimmermann; Irene Ginis; K Furuya; Dace Klimanis; Christl Ruetzler; Maria Spatz; John M Hallenbeck
Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.
Brain research 2001;895(1-2):59-65.
2001: Christl Ruetzler; K Furuya; H Takeda; John M Hallenbeck
Brain vessels normally undergo cyclic activation and inactivation: evidence from tumor necrosis factor-alpha, heme oxygenase-1, and manganese superoxide dismutase immunostaining of vessels and perivascular brain cells.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2001;21(3):244-52.
2001: K Furuya; Irene Ginis; H Takeda; Yong Chen; John M Hallenbeck
Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2001;21(3):226-32.
1999: D A Dawson; K Furuya; J Gotoh; Y Nakao; John M Hallenbeck
Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(6):616-23.